Keck School of Medicine
United States of America
Barzi earned her M.D. from Tehran University of Medical Sciences, then went on to earn a Master’s in Health Informatics and a Doctorate in Public Health Management and Policy Sciences from the University of Texas Health Science Center in Houston. She recently completed a fellowship in hematology and oncology at the Cleveland Clinic’s Taussig Cancer Center.
the development of new cancer therapies as well as healthcare economics and metrics of healthcare quality for improving patient care.
Fujii T, Barzi A, Sartore-Bianchi A, Cassingena A, Siravegna G, Karp D, Piha-Paul S, Subbiah V, Tsimberidou AM, Huang H, Veronese S. Mutation-enrichment next-generation sequencing for quantitative detection of KRAS mutations in urine cell-free DNA from patients with advanced cancers. Clinical Cancer Research. 2017 Jan 1:clincanres-2592.
Barzi A, Klein EA, Daneshmand S, Gill I, Quinn DI, Sadeghi S. Access to high-volume surgeons and the opportunity cost of performing radical prostatectomy by low-volume providers. InUrologic Oncology: Seminars and Original Investigations 2017 Mar 9. Elsevier.
Schirripa M, Zhang W, Heinemann V, Cao S, Okazaki S, Yang D, Loupakis F, Berger MD, Ning Y, Miyamoto Y, Suenaga M. Single nucleotide polymorphisms in the IGF‐IRS pathway are associated with outcome in mCRC patients enrolled in the FIRE‐3 trial. International Journal of Cancer. 2017 Jul 15;141(2):383-92.